Probiotic

Critically ill patients who required mechanical ventilation and received the probiotic Lactobacillus rhamnosus GG were as likely to develop ventilator-associated pneumonia as those who received placebo, a randomized clinical trial showed.

Women with polycystic ovary syndrome who take probiotics and synbiotics may see some “partially beneficial effect” on indices of insulin resistance, according to a meta-analysis published in the Journal of International Medical Research.

Spore-forming probiotics were safe and effective in the treatment of patients with functional dyspepsia, according to research published in the Lancet Gastroenterology and Hepatology.

In children with acute gastroenteritis, probiotics did not offer benefits, regardless of diarrhea timing or severity, according to a study published in the American Journal of Gastroenterology.

Atopic dermatitis symptoms were improved in patients who received selected probiotic strains, according to a study.

The rate of hospital-acquired Clostridioides difficile infection improved by 39% at a Quebec hospital when 70% of antibiotic users took a three-strain Lactobacillus probiotic under a pharmacy-driven protocol, researchers reported.

This week, a monoclonal antibody cocktail cut COVID-19 hospitalization and death; removing race correction in lung function tests shows more severe disease in Black patients; gefapixant reduces chronic cough frequency in a large pooled analysis; and more.

ACG developed guidelines for the preferred management of adults with Clostridioides difficile infection, published in the American Journal of Gastroenterology.

Daily probiotic use correlated with a reduction in upper respiratory tract infection symptoms among overweigh individuals, according to a presentation at the Digestive Disease Week media briefing.

In this episode, Brian E. Lacy, MD, PhD, joins us to discuss the American College of Gastroenterology’s newest guidelines for irritable bowel syndrome, options for patients with IBS-D and IBS-C, and much more.